Seven Bridges is the biomedical data analysis company accelerating breakthroughs in genomics research for cancer, drug development and precision medicine. We democratize genomics by enabling researchers anywhere to process and understand genomic data faster and more efficiently than ever, at any scale. Thousands of researchers in government, biotech, pharmaceutical and academic labs use Seven Bridges, including three of the largest genomics projects in the world: U.S. National Cancer Institute’s Cancer Genomics Cloud pilot, honored with the Bio-IT World Best of Show award 2016, the Million Veteran Program, and Genomics England’s 100,000 Genomes Project. As the NIH’s only commercial Trusted Partner, Seven Bridges authenticates and authorizes access to one of the world’s largest cancer genomics dataset. Seven Bridges has been recognized by the MIT Technology Review as one of the Top 50 Smartest Companies in the World in 2016.